GenVec Inc.
910 Clopper Road
Suite 220N
Gaithersburg
Maryland
20878
United States
Tel: 240-632-0740
Fax: 240-632-0735
Website: http://www.genvec.com/
255 articles about GenVec Inc.
-
Intrexon Integrates Leading Adenoviral Gene Delivery Technology With Completion of GenVec Acquisition
6/16/2017
-
Intrexon Release: Company To Acquire GenVec To Expand Industry-Leading Gene Delivery Platform
1/24/2017
-
GenVec Signs Option Agreement For Gene Editing And Cell Targeting Technology From Washington University in St. Louis
1/5/2017
-
GenVec Effects 1-for-10 Reverse Stock Split
12/1/2016
-
GenVec Reports Third Quarter 2016 Financial Results
11/4/2016
-
GenVec To Present At 2016 Cell & Gene Meeting On The Mesa
9/28/2016
-
GenVec Will Not be Affected by Novartis AG' Dissolution of CAR-T Unit
9/1/2016
-
GenVec Reports Second Quarter 2016 Financial Results
8/5/2016
-
FDA Lifts Clinical Hold on GenVec's Hearing Loss Candidate
7/25/2016
-
GenVec Reports First Quarter 2016 Financial Results
5/12/2016
-
GenVec Announces $5 Million At-The-Market Offering
5/5/2016
-
GenVec Provides Update On Hearing Loss Clinical Program
5/2/2016
-
GenVec Reports Fourth Quarter And 2015 Year-End Financial Results
3/9/2016
-
GenVec To Release Fourth Quarter And Year-End 2015 Financial Results And Conduct A Conference Call On March 9, 2016
3/2/2016
-
GenVec in Limbo Awaiting Novartis AG's Decision on Status of Lead Drug CGF166
1/20/2016
-
GenVec Inc. Receives Notice Of Allowance For Patent Application Providing Broad Protection Of Its Gorilla Adenovectors
12/2/2015
-
GenVec Inc. Reports Third Quarter 2015 Financial Results
11/9/2015
-
GenVec Inc. Highlights Gorilla Adenovectors At Vaccines R&D-2015 Conference
11/4/2015
-
GenVec Inc. To Present At 2015 Stem Cell Meeting On The Mesa
9/30/2015
-
GenVec Inc. Expands I.P. Portfolio With Issuance Of U.S. And European Patents For Monkey Adenoviral Vectors
9/28/2015